Merck & Company Inc (MRK)
Official siteHEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE
Market Cap: $356.13B
Last updated: Nov 17, 2026 at 4:43 PM ET
Merck & Company Inc (MRK) Stock Chart
Merck & Company (MRK) has a latest price of $143.39 on Nov 17, 2026, 8.1% below its 52-week high of $156.00. Its price rose 56.8% over the past 12 months. The month-end price rose 154.6% over the 10 years through Oct 2026, a compound annual rate of 9.8%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $149.52 in Oct 2026 and its lowest $54.22 in Feb 2018, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart MRK with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for MRK.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 5.2%, and over 6 months it rose 27.2%. The month-end price rose 45.6% over the 3 years through Oct 2026, a compound annual rate of 13.3%.
| Period | Change |
|---|---|
| 1 month | -0.2% |
| 3 months | -5.2% |
| 6 months | +27.2% |
| 12 months | +56.8% |
| 12 months, with dividends | +60.5% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +45.6% | +13.3% |
| 5 years | +69.8% | +11.2% |
| 10 years | +154.6% | +9.8% |
Price by Year
Its best calendar year was 2022, when the price rose 44.8%, and its weakest was 2020, when it fell 10.1%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $149.52 | +42.0% |
| 2025 | $105.26 | +5.8% |
| 2024 | $99.48 | -8.8% |
| 2023 | $109.02 | -1.7% |
| 2022 | $110.95 | +44.8% |
| 2021 | $76.64 | -6.3% |
| 2020 | $81.80 | -10.1% |
| 2019 | $90.95 | +19.0% |
| 2018 | $76.41 | +35.8% |
| 2017 | $56.27 | -4.4% |
Trading Range
The price is 1.7% below its 50-day average of $145.85 and 11.9% above its 200-day average of $128.09.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $143.39 | |
| 52-week high | $156.00 | -8.1% |
| 52-week low | $91.22 | +57.2% |
| 50-day average | $145.85 | -1.7% |
| 200-day average | $128.09 | +11.9% |
Price Risk
Over 3 years, its largest fall from a peak was 43.5%.
| Measure | Value |
|---|---|
| 1-year beta | 0.25 |
| Largest fall, 1 year | -11.9% |
| Largest fall, 3 years | -43.5% |
Valuation
Merck & Company traded at 11.7x earnings at the end of 2025, against a 5-year median of 14.6x and a 10-year median of 15.3x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About MRK
What is MRK's 1-year price change?
Merck & Company's price rose 56.8% over the past 12 months. With dividends included, the 12-month total return was 60.5%.
What is MRK's 5-year price change?
Merck & Company's month-end price rose 69.8% over the 5 years through Oct 2026, a compound annual rate of 11.2%. These figures leave out dividends.
What is MRK's 52-week high and low?
Merck & Company's 52-week high is $156.00 and its 52-week low is $91.22. Its latest price of $143.39 on Nov 17, 2026 is 8.1% below the high.
What is MRK's beta?
Merck & Company's 1-year beta against the S&P 500 is 0.25, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 11.9%.
Is the MRK chart free?
Yes. Advanced Charting for MRK is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
MRK pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts